Printer Friendly

Articles from The Fly (June 8, 2020)

1-95 out of 95 article(s)
Title Author Type Words
Aerpio Pharmaceuticals to host KOL call on novel mechanism for glaucoma. 190
Agios gets FDA orphan drug designation for mitapivat for thalassemia treatment. 202
Aimmune announces two-year Palforzia data in patients with peanut allergy. 338
Altisource to withhold votes for two Front Yard board nominees. 432
Asian Market Update:. 217
Avocado-distributor Calavo sees Q3 adjusted EBITDA to improving sequentially. 222
Axovant completes enrollment of low-dose cohort in Phase 1/2 AXO-AAV-GM1 stusy. 278
Bachoco cements agreement to invest in processed pig business in Mexico. 157
Beacon Roofing quarter-to-date performance 'exceeded expectations'. 211
Biolase announces pricing of $6.9M registered direct offering. 218
Bionano Genomics issued U.S. patent for nanochannel nanopore device. 223
Boeing price target raised to $238 from $209 at Goldman Sachs. 153
Cabot says liquidity position remains sound amid amended credit facilities. 207
Catalyst Biosciences announces presentations at hemophilia virtual summit. 175
Cemtrex closes $5.5M registered direct offering priced at-the-market. 154
Chembio Diagnostics receives FDA 510(k) clearance for DPP Zika IgM System. 200
China Distance Education receives non-binding proposal to acquire company. 244
Cinedigm launches global animation network CONtv Anima. 166
Citi sees low probability of AstraZeneca acquiring Gilead. 157
Clearwater Paper expects to outperform previous FY expectations. 226
CNH Industrial announces updates on investment in Nikola. 251
Commvault announces board agreement with Starboard. 185
Conduent holder Trillium calls to split company into 3 segments or sell company. 1494
Credicorp announces expansion of board of directors to nine from eight. 282
Deciphera announces INVICTUS study results published. Clinical report 221
DFAM issues letter to OneSpaWorld shareholders regarding $75M financing. 472
Ebix considers countersuit against Yatra following merger deal termination. 252
Egan-Jones recommends Mack-Cali shareholders vote for Bow Street nominees. 267
Ekso Bionics announces $7.89M registered direct offering priced at-the-market. 179
Elanco reports EC approves pending acquisition of Bayer animal health business. 152
ElectraMeccanica begins proposed site visits in search for EV U.S. facility. 329
Eli Lilly begins Phase 1 study for second potential COVID-19 antibody treatment. 199
EMA announces application for conditional authorization of remdesivir for COVID. 153
Endra Life Sciences announces new clinical study partnership with MCW. Clinical report 156
Enochian Biosciences completes FDA INTERACT meeting on ENOB-HV-01. 181
FibroGen enrolls first patient in pamrevlumab clinical trial. Clinical report 214
FibroGen plans initiation of two additional Phase 2 studies of pamrevlumab. 169
FibroGen's phase 3 study of roxadustat shows non-inferiority in CKD. Clinical report 269
Five Below price target raised to $132 from $105 at Craig-Hallum. 154
Flir Systems launches Screen-EST software to improve temperature screening. 207
Fly Intel: Top five analyst downgrades. 246
Fly Intel: Top five analyst upgrades. 240
FOMC Forecast revisions. 266
FOMC preview: this week's FOMC meeting shouldn't be eventful. 238
FX Update: The dollar majors have remained in narrow ranges. 286
FX Update: The dollar majors have remained in narrow ranges. 302
Genius Brands CEO responds to 'misleading' short seller criticisms. 1393
Gilead shares worth at least $120 in takeover by AstraZeneca, says Piper Jaffray. 174
Global Blood Therapeutics to seek expanded labeling for Oxbryta. 161
Google Maps incorporates new COVID-19 travel alerts amid reopenings. 242
Habit Burger Grill announces partnership with Impossible Foods. 157
Hercules Capital receives SBA 'green light' letter approval. 169
Hurco Companies reports Q2 EPS (58c) vs. 76c last year. 346
IFF says currency neutral sales down 3% through first eight weeks of Q2. 341
Innovent Biologics to partner with Roche on product development. 163
Kindred Biosciences to reduce operating expenses, cut about 25 employees. 271
Kiniksa announces 28-day outcomes data from mavrilimumab treatment protocol. Clinical report 432
Macy's raises approximately $4.5B in financing. 263
Materion to acquire Optics Balzers. 222
Myriad Genetics announces publication of study on GeneSight Psychotropic test. 194
National Vision estimates one-month April SSS down 83.9%, May down 56.6%. 154
Nebula Acquisition, Open Lending announce intent to close business combination. 182
Neurocrine: Phase II crinecerfont study showed reductions in key biomarkers. 186
New York Times confirms resignation of opinion editor James Bennet. 177
NovaGold chairman addresses 'misleading' report by JCAP. 215
NovaGold chairman addresses short seller report. 611
NovaGold provides response to 'misleading, false' short-seller report. 261
O-I Glass sees FY20 volumes down 5%-10%. 234
O3 Mining mobilizes second drill as part of 150,000 meter drill program. 238
ON Semiconductor adopts short-term shareholder rights plan. 572
OneSmart says large number of offline centers have reopened. 153
Opes Acquisition announces LOI for business combination with BurgerFi. 376
OraSure Oragene Dx included in EUA for use with SARS-CoV-2 test. 193
PG&E announces $3.25B common stock investment from multiple investors. 391
PG&E to pursue $5.75B offerings of stock, equity units. 354
PPG initiates global restructuring, targets $170M in annual savings. 186
PPG says April sales volumes down approximately 35% y/y. 167
RTI Surgical announces filing of 2019 10-K, completion of financial restatement. 168
Sarepta announces expression, functional data from SRP-9003 gene therapy trail. 507
Sino-Global signs General Agency Service Agreement with Mandarine Bulk. 166
Soleno Phase III trial does not meet primary endpoint. 212
Stitch Fix reports Q3 EPS (33c), consensus (16c). Financial report 177
ThermoGenesis announces publication of joint venture's COVID-19 antibody article. 202
Thor Industries provides update amid COVID-19 pandemic. 338
Thor Industries says North America market indicators are increasingly positive. 453
TOP Ships announces pricing of $20M registered direct offering. 156
Treasury Action: the $44 B 3-year note auction headlines today. 220
Treasury Market Outlook: U.S. equity futures extended gains. 307
Treasury's $117 B 3- and 6-month bill auctions were mixed. 214
Treasury's $44 B 3-year note auction was well received and garners about a B+ grade. 263
U.S. equity futures are mostly higher. 233
Urban Tea receives regulatory approval to seek franchisees for growth in China. 182
Urstadt Biddle reports Q2 FFO 27c, consensus 34c. 219
XP Inc. acquires majority stake in Fliper, terms not disclosed. 202
Xylem beats greenhouse gas reduction target by over 40%. 197

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters